MedTrace Logo

Cancer of the Lung And SeneScencE - Prospective Cohort 1

NCT06923618 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 385

Last updated 2025-12-15

No results posted yet for this study

Summary

The main objective is to identify and assess the predictive value of ageing and senescence biomarkers (methylome, telomeres, inflammageing) and senescent cells in tissues to improve prognosis assessment older patients with locally or locally-advanced Non-Small Cell Lung Cancer (NSCLC).

Conditions

Interventions

BIOLOGICAL

Blood samples

Blood samples (5 ml) during surgery or within 3 days before.

Sponsors & Collaborators

  • ARC Foundation and Inserm

    collaborator UNKNOWN

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Florence CANOUÏ-POITRINE, PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-09
Primary Completion
2028-07-31
Completion
2032-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06923618 on ClinicalTrials.gov